Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.98Price to Sales
VS
Market
Sector
Industry
History
$ 10.54Close
$ 5.97 - $ 67 52-Week Range
Ticker Information
Ticker
MRSNCompany Name
MERSANA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMERSANA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MRSN - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 33.99M | 0.98 | $ 34.77M |
| 3/31/2025 | $ 39.19M | 1.15 | $ 34.01M |
| 12/31/2024 | $ 59.82M | 1.48 | $ 40.5M |
| 9/30/2024 | $ 324.89M | 9.33 | $ 34.84M |
| 6/30/2024 | $ 165.61M | 5.53 | $ 29.94M |
| 3/31/2024 | $ 301.62M | 7.88 | $ 38.3M |
| 12/31/2023 | $ 588.32M | 15.96 | $ 36.85M |
| 9/30/2023 | $ 161.58M | 3.96 | $ 40.84M |
| 6/30/2023 | $ 148.22M | 3.83 | $ 38.72M |
| 3/31/2023 | $ 915.09M | 28.29 | $ 32.35M |
Key Performance Insights, Last 5 Years
- MERSANA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 1.83K.
- Over the past 5 years, MERSANA THERAPEUTICS INC's average P/S has been 2.46K.
- The median P/S for MERSANA THERAPEUTICS INC during this period was 26.46
- MERSANA THERAPEUTICS INC reached its highest P/S over the past 5 years at 20.17K.
- The lowest P/S recorded by MERSANA THERAPEUTICS INC in the same timeframe 0.98
MERSANA THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for MERSANA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.57B ] / Revenues [ $ 860K ]
(=) P/S [ 1.83K ] MRSN - Price to Sales, Last 5 years
0.98
Minimum
Jun 30, 2025
20.17K
Maximum
Jun 30, 2021
2.46K
Average
26.46
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |